Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)?

Overview of attention for article published in BMC Medicine, August 2009

Altmetric Badge

Mentioned by

patent: 1 patent

Readers on

mendeley: 26 Mendeley

Summary Patents

So far, Altmetric has seen 1 patent that references this research output.

BIOMARKERS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

Application WO-2013106686-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.